Pharmaceutical News

RSS

"Drug checking" programs have unexpected benefits, study finds

A recent study has found that so-called "drug checking" programs have unexpected benefits, allowing public health programs to reach and work with people who use drugs who would otherwise not access services such as HIV testing.

7 Feb 2022

Paracetamol use increases blood pressure, study shows

Long-term paracetamol use could increase the risk of heart disease and strokes in people with high blood pressure, a study suggests.

7 Feb 2022

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Researchers discuss the impact of mRNA booster immunization on the neutralizing activity against the SARS-CoV-2 Omicron variant in the elderly.

6 Feb 2022

Nuvaxovid COVID-19 vaccine given regulatory approval By MHRA

Nuvaxovid, the COVID-19 vaccine developed by Novavax, has today been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).

3 Feb 2022

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Researchers evaluate the neutralization potential of sera samples from subjects boosted with the Covaxin against the SARS-CoV-2 Omicron variant.

2 Feb 2022

Developing post-vaccination SARS-CoV-2 standard reference sera

A new study reports the generation of reference sera reagents that were obtained from subjects vaccinated with one of four COVID-19 vaccines.

1 Feb 2022

High levels of neutralizing antibodies against Omicron after BNT162b2 booster vaccination

Researchers analyze the neutralizing antibody levels against SARS-CoV-2 VOCs in individuals after receiving their second and third doses.

1 Feb 2022

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

A new study has assessed the antibody responses to the mRNA-1273 Moderna vaccine over time.

31 Jan 2022

Preliminary study assesses durability of NAb titers against Omicron after mRNA-1273 booster

Researchers from Moderna, the developers of one key vaccine, have been investigating its ability to protect against the Omicron variant.

31 Jan 2022

Study finds limited evidence for IL-1 blockers in treating COVID-19

Researchers assess the effectiveness and safety outcomes of interleukin-1 blocking agents in the treatment of COVID-19.

31 Jan 2022

Children and adolescents respond as well or better than adults to mRNA-1273 COVID vaccination

A recent study assesses the neutralization efficacy of the mRNA-1273 vaccine against the SARS-CoV-2 Omicron variant in children, adolescents, and adults.

30 Jan 2022

Study shows homologous COVID boosters better than heterologous in most kidney transplant recipients

Researchers screen kidney transplant recipients to evaluate their serological responses following immunization with three doses of the COVID-19 vaccine.

30 Jan 2022

COVID-19 vaccines elicit cross-reactive antibodies against endemic coronaviruses

Researchers study the interaction between immunity to endemic coronaviruses and SARS-CoV-2.

30 Jan 2022

Escape from vaccine-induced immunity likely contributed to rapid rise of SARS-CoV-2 Omicron

Researchers investigate whether the SARS-CoV-2 Omicron variant is more likely to infect vaccinated individuals than the SARS-CoV-2 Delta variant.

30 Jan 2022

Treating COVID with antibiotics could be a much simpler way of making people better

A recent study conducted in an Egyptian hospital showed that treating moderate-to-severe COVID patients with either one of two antibiotics (ceftazidime or cefepime, in combination with a steroid) resulted in similar recovery times compared to patients given standard treatment.

29 Jan 2022

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested to advance ocular drug discovery and development.

29 Jan 2022

Hospitalized COVID-19 patients more likely to experience heavy bleeding when prescribed full-dose blood thinners

Patients with COVID-19 in the intensive care unit (ICU) prescribed full-dose blood thinners are significantly more likely to experience heavy bleeding than patients prescribed a smaller yet equally effective dose, according to a recent University at Buffalo-led study.

28 Jan 2022

Pharmaceutical News

"Drug checking" programs have unexpected benefits, study finds

Paracetamol use increases blood pressure, study shows

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Nuvaxovid COVID-19 vaccine given regulatory approval By MHRA

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Developing post-vaccination SARS-CoV-2 standard reference sera

High levels of neutralizing antibodies against Omicron after BNT162b2 booster vaccination

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Preliminary study assesses durability of NAb titers against Omicron after mRNA-1273 booster

Study finds limited evidence for IL-1 blockers in treating COVID-19

Children and adolescents respond as well or better than adults to mRNA-1273 COVID vaccination

Study shows homologous COVID boosters better than heterologous in most kidney transplant recipients

COVID-19 vaccines elicit cross-reactive antibodies against endemic coronaviruses

Escape from vaccine-induced immunity likely contributed to rapid rise of SARS-CoV-2 Omicron

Treating COVID with antibiotics could be a much simpler way of making people better

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Hospitalized COVID-19 patients more likely to experience heavy bleeding when prescribed full-dose blood thinners

Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

E406W mutation on SARS-CoV-2 RBD escapes monoclonal antibody cocktail-mediated neutralization

Psychedelic analogs show antidepressant-like activity in mice without causing hallucination

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News